Company Filing History:
Years Active: 2014
Title: In Jin Jang: Innovator in Antihypertensive Pharmaceutical Composition
Introduction
In Jin Jang is a notable inventor based in South Korea, recognized for his contributions to the field of pharmaceuticals. He has developed an innovative antihypertensive pharmaceutical composition that aims to improve treatment options for patients with hypertension.
Latest Patents
In Jin Jang holds a patent for an antihypertensive pharmaceutical composition that includes Fimasartan, an angiotensin II receptor blocker, and Amlodipine, a calcium channel blocker. This combination is designed to enhance the efficacy of hypertension treatment. Despite having 1 patents, his work in this area is significant.
Career Highlights
Jang is associated with Boryung Pharmaceutical Co., Ltd., a company that focuses on developing advanced pharmaceutical solutions. His role in the company has allowed him to contribute to important research and development projects aimed at improving patient care.
Collaborations
He has collaborated with notable colleagues, including Seung Ho Kim and Ji Han Kim, who share a commitment to advancing pharmaceutical innovations.
Conclusion
In Jin Jang's work in antihypertensive pharmaceutical compositions showcases his dedication to improving healthcare solutions. His contributions, although currently limited in patent count, reflect a promising direction in pharmaceutical research.